Sponsor Pipeline

Vandana Abramson Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07016399 Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA… Anatomic Stage II Breast Cancer AJCC v8 Recruiting
Disease Areas
Get alerts when Vandana Abramson's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free